Stephens analyst Brett Huff lowered the firm’s price target on Braze (BRZE) to $41 from $51 and keeps an Overweight rating on the shares. The firm thinks the Q1 pros are greater than the cons and calls the company’s growth resilience “remarkable” even with a sequential deceleration in subscription revenue and lower sequential NRR.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BRZE:
- Braze’s Strong Performance and Strategic Acquisition Reinforce Buy Rating
- Braze, Inc. Reports Strong Growth and Strategic Moves
- Closing Bell Movers: Lululemon falls over 20% on soft guidance
- Braze Reports Q1 2026 Revenue Growth and Leadership Change
- Braze down 14% at $31.00 after Q1 results, FY26 EPS guidance cut